0000899243-22-025817.txt : 20220708
0000899243-22-025817.hdr.sgml : 20220708
20220708161011
ACCESSION NUMBER: 0000899243-22-025817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morgan Leigh
CENTRAL INDEX KEY: 0001935887
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 221074506
MAIL ADDRESS:
STREET 1: KYMERA THERAPEUTICS, INC.
STREET 2: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-06
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001935887
Morgan Leigh
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
1
0
0
0
Stock Option (Right to Buy)
23.59
2022-07-06
4
A
0
24000
0.00
A
2032-07-05
Common Stock
24000
24000
D
The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on July 6, 2022..
/s/ Bruce Jacobs, as Attorney-in-Fact
2022-07-08